TrialAnnals of the rheumatic diseases2013
Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study.
Arthur Kavanaugh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this paperpooled ittrialcites it